The Guangdong-Hong Kong-Macao Greater Bay Area High-Performance Medical Device Innovation Center (hereinafter referred to as the "Innovation Center") is a platform focusing on innovative research and efficient industrial transformation in the field of high-performance medical devices. It was inaugurated by provincial, municipal, and district leaders at the 3rd Guanzhou International Biotech Forum in June 2019, and has been successively listed in the 2020 Guangzhou Key Construction Project Plan and the 2020 Guangzhou "City-Seizing" Key Construction Project Plan.
Guangzhou Chuangjing Medical Technology Co., Ltd., as the corporate operating entity of the Innovation Center, builds a resource network deeply integrating innovation, industry, talent, and finance for the Innovation Center. It is jointly established by a large state-owned entity of Guangzhou Development District and well-known enterprises in the medical device industry, with a registered capital of 100 million yuan, committed to making the Innovation Center a highland for composite industrial talents, a hub for innovative achievements, and an incubation base for technology innovation enterprises.
Guangzhou Yijie Medical Technology Co., Ltd. (hereinafter referred to as "Yijie Medical"), as a technology-based innovative enterprise successfully incubated by the "Innovation Center," integrates R&D, production, and sales of high-end interventional medical devices. It is committed to becoming a "developer of innovative neurointerventional devices that understand clinical needs and patients," seeking solutions for unmet clinical needs through professional product development and commercialization capabilities.
Yijie Medical was recognized as a national technology-based SME in June 2021. It boasts multiple cross-disciplinary industrial innovation talents and implements a deep "med-engineering integration" strategy throughout the entire lifecycle of medical device development. It has established complete R&D and industrialization platforms for four key technologies: guidewires, catheters, balloons, and stents, achieving the development of products such as micro-guidewires, thrombus aspiration catheters, and stent retrievers. It has built a GMP-compliant class 10,000 cleanroom R&D and production workshop, equipped with internationally advanced research and production facilities to safeguard R&D and production.
Driven by factors such as population aging, the demand for neurointerventional procedures in China continues to rise, and the potential for future development of the neurointerventional market is enormous. Yijie Medical will always adhere to the tenet of "med-engineering integration, independent innovation, and collaborative R&D," persistently innovating and relentlessly pursuing to provide patients with safer and more effective cerebrovascular protection and treatment solutions, aiming to contribute to driving the upgrading of the neurointerventional industry, promoting the rapid development of China's medical and health industry, and improving people's health.
We welcome ambitious individuals to join us and contribute to the innovative development of domestic high-performance medical devices.
What does Guangzhou Chuangjing Medical Technology Co., Ltd. require? Who is Guangzhou Chuangjing Medical Technology Co., Ltd. hiring? recruitment: 销售类占比最多占33.7%，其次是医疗卫生/美容保健类占26.5%. What education can get in at ? 大专占比最多占43.4%，其次是本科占42.2%. High education required at ? 硕士占9.6%. Work experience required at ? 1-3年占比最多占41%，其次是不限占26.5%. Where are the job locations at ? 广州占比最多占69.9%，其次是北京占3.6%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
